- Potential benefits for participants: PIPAC may potentially be similarly or even more effective against peritoneal metastases than chemotherapy through the veins, with a potential lower risk of side-effects. There may be a small chance (+/- 10%) that the peritoneal metastases become so small that they can be cured by surgery. However, these potential benefits are uncertain. The cancer may deteriorate at any moment during treatment with PIPAC.